Revenue Update on Avinger Inc(NASDAQ:AVGR)

Avinger Inc(NASDAQ:AVGR) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 1, 2016. Company reported revenue of $4.68M. Analysts estimated a revenue of $5.70M. Earnings per share were $-1.06. Analysts had estimated an EPS of $-1.12.

Avinger Inc (AVGR) made into the market gainers list on Mondays trading session with the shares advancing 1.74% or 0.08 points. Due to strong positive momentum, the stock ended at $4.67, which is also near the day’s high of $4.79. The stock began the session at $4.62 and the volume stood at 1,81,815 shares. The 52-week high of the shares is $25.11 and the 52 week low is $4.22. The company has a current market capitalization of $59 M and it has 1,26,93,485 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On Jul 25, 2016, John D. Simpson (Sr. VP, Sales & Marketing) sold 32,500 shares at $6.28 per share price.Also, On May 10, 2016, Himanshu Patel (CTO) sold 10,000 shares at $13.40 per share price.On Apr 19, 2016, John B Ph D Md Simpson (Executive Chairman) sold 75,111 shares at $13.11 per share price, according to the Form-4 filing with the securities and exchange commission.

Avinger Inc. is a commercial-stage medical device company. The Company designs manufactures and sells image-guided catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and select European markets. The Company’s products include Lightbox imaging console as well as Wildcat Kittycat and the Ocelot family of catheters which are designed to allow physicians to penetrate a total blockage in an artery known as a chronic total occlusion (CTO). The Company’s lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Avinger Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Avinger Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.